Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102052136 | 10205213 | 6 | F | 1995 | 20160907 | 20140529 | 20160913 | EXP | US-PFIZER INC-2014146773 | PFIZER | 24.00 | YR | F | Y | 56.34000 | KG | 20160913 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102052136 | 10205213 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
| 102052136 | 10205213 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 3X/DAY | 21446 | 100 | MG | CAPSULE, HARD | TID | ||||||
| 102052136 | 10205213 | 3 | C | CARISOPRODOL. | CARISOPRODOL | 1 | Oral | 350 MG, AS NEEDED (2 TIMES DAILY AS NEEDED) | 0 | 350 | MG | TABLET | |||||||
| 102052136 | 10205213 | 4 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | Oral | [HYDROCODONE BITARTRATE 5MG-PARACETAMOL 325MG], 2X/DAY | 0 | 1 | DF | TABLET | BID | ||||||
| 102052136 | 10205213 | 5 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 10 MG, 1X/DAY (NIGHTLY) | 0 | 10 | MG | TABLET | QD | ||||||
| 102052136 | 10205213 | 6 | C | EPINEPHRINE. | EPINEPHRINE | 1 | Intramuscular | 0.3 MG, AS NEEDED (INJECT 0.3 MLS (0.3 MG TOTAL) INTO THE MUSCLE ONCE AS NEEDED) | 0 | .3 | MG | INJECTION | |||||||
| 102052136 | 10205213 | 7 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | CAPSULE | |||||||
| 102052136 | 10205213 | 8 | C | LEVALBUTEROL. | LEVALBUTEROL | 1 | INHALE 1-2 PUFFS INTO THE LUNGS EVERY 4 HOURS AS NEEDED | 0 | INHALATION GAS | ||||||||||
| 102052136 | 10205213 | 9 | C | DIMETHYL FUMARATE | DIMETHYL FUMARATE | 1 | Oral | 120 MG, 2X/DAY | 0 | 120 | MG | BID | |||||||
| 102052136 | 10205213 | 10 | C | IRON POLYSACCHARIDES | 2 | Oral | 150 MG, DAILY | 0 | 150 | MG | CAPSULE | ||||||||
| 102052136 | 10205213 | 11 | C | DIAZEPAM. | DIAZEPAM | 1 | 2 MG, AS NEEDED (2 MG EVERY 6 (SIX) HOURS AS NEEDED ) | 0 | 2 | MG | TABLET | ||||||||
| 102052136 | 10205213 | 12 | C | ESCITALOPRAM OXALATE. | ESCITALOPRAM OXALATE | 1 | Oral | 1.5 MG, DAILY | 0 | 1.5 | MG | TABLET | |||||||
| 102052136 | 10205213 | 13 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0.5 MG (TAKE 0.5 MG NIGHTLY AS NEEDED/1/2 TABLET EVERY OTHER DAY) | 0 | .5 | MG | TABLET | |||||||
| 102052136 | 10205213 | 14 | C | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | ACETAMINOPHENBUTALBITALCAFFEINE | 1 | Oral | [BUTALBITAL 50MG, CAFFEINE 40MG, PARACETAMOL 325MG], 4X/DAY | 0 | 1 | DF | TABLET | QID | ||||||
| 102052136 | 10205213 | 15 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | [HYDROCODONE BITARTRATE 5 MG-PARACETAMOL 325 MG], UNK | 0 | 1 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102052136 | 10205213 | 1 | Fibromyalgia |
| 102052136 | 10205213 | 3 | Muscle spasms |
| 102052136 | 10205213 | 8 | Wheezing |
| 102052136 | 10205213 | 13 | Sleep disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102052136 | 10205213 | DS |
| 102052136 | 10205213 | OT |
| 102052136 | 10205213 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102052136 | 10205213 | Arthritis | |
| 102052136 | 10205213 | Central nervous system lesion | |
| 102052136 | 10205213 | Cervicobrachial syndrome | |
| 102052136 | 10205213 | Communication disorder | |
| 102052136 | 10205213 | Drug ineffective | |
| 102052136 | 10205213 | Dysphemia | |
| 102052136 | 10205213 | Fatigue | |
| 102052136 | 10205213 | Headache | |
| 102052136 | 10205213 | Memory impairment | |
| 102052136 | 10205213 | Migraine | |
| 102052136 | 10205213 | Multiple sclerosis | |
| 102052136 | 10205213 | Nervous system disorder | |
| 102052136 | 10205213 | Road traffic accident | |
| 102052136 | 10205213 | Thought blocking |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102052136 | 10205213 | 2 | 20160831 | 0 | ||
| 102052136 | 10205213 | 15 | 20160801 | 20160826 | 0 |